Legacy Financial Advisors »

Neurocrine Biosciences shares owned by Legacy Financial Advisors

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Legacy Financial Advisors from 13F filings

Historical chart of Legacy Financial Advisors investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Legacy Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Legacy Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $227k 1.6k 141.83
2018-09-30 $66k 540 122.22

More positions owned by Legacy Financial Advisors

Wisdomtree Us Quality Dividend Growth Fund Etf (DGRW)
Franklin International Core Dividend Tilt Index Fund Etf (DIVI)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Wisdomtree Us Value Fund Of Benef Interest Etf (WTV)
Wisdomtree True Emerging Markets Fund Etf (XC)
Pimco Multisector Bond Active Exchange-traded Fund Etf (PYLD)
Wisdomtree U.s. Quality Growth Fund Etf (QGRW)
Microsoft Stock (MSFT)
Natixis Gateway Quality Income Etf Etf (GQI)
Ishares Core Dividend Growth Etf Etf (DGRO)
Procter & Gamble Stock (PG)
Jpmorgan Municipal Etf Etf (JMUB)
Amazon.com Stock (AMZN)

View all positions for Legacy Financial Advisors

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
Jpmorgan Chase & Co
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Wellington Management Company
Bellevue Group
Bnp Paribas Investment Partners
Thomas Stevens, CFA"
Northern Trust
Deerfield Management Company
Norges Bank Investment Management

View all funds holding Neurocrine Biosciences